Brief: Ind Swift Laboratories Approves Slump Sale Of API Business To Synthimed Labs
Sept 6 (Reuters) - IND Swift Laboratories Ltd ISLB.NS :
* APPROVED INVESTMENT OF 800 MILLION RUPEES TO SYNTHIMED
LABS PVT
LTD
* APPROVED IN-PRINCIPALLY, AMALGAMATION OF IND-SWIFT LTD
WITH CO
* APPROVED SLUMP SALE OF API BUSINESS TO SYNTHIMED LABS FOR
16.50
BILLION RUPEES
Source text for Eikon: ID:nBSE2ChfL3
Further company coverage: ISLB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on IND Swift Laboratories
See all newsBrief: Ind Swift Laboratories Upgrading Manufacturing Facility Located At J&K To EU-GMP/Pics Standards
Brief: Ind Swift Laboratories June-Quarter Consol Net PAT 246.8 Million Rupees
Brief: Ind Swift Laboratories Enters MoU With Him Infratech For Warehouse Construction On July 28, 2026
Brief: Ind Swift Laboratories To Consider Raising Of Funds By Way Of Issuance Of One Or More Instruments
Brief: Ind Swift Laboratories Says Tribunal Rejected All Claims Of PI Industries, Counterclaims Of Co, Others